Showing results 211 to 230 of 459
< previous
next >
| Issue Date | Title | Author(s) |
| 2014-01-01 | Lessons from the Liverpool Care Pathway-evidence is key | Currow, DC; Abernethy, AP |
| 2017-06-01 | Living actively in the face of impending death: Constantly adjusting to bodily decline at the end-of-life | Morgan, DD; Currow, DC; Denehy, L; Aranda, SA |
| 2012-12-01 | Longitudinal pain reports in a palliative care population | Clark, K; Smith, J; Lovell, M; Currow, DC |
| 2013-08-01 | The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea | Currow, DC; Quinn, S; Greene, A; Bull, J; Johnson, MJ; Abernethy, AP |
| 2015-01-01 | Look back for the Charlson index did not improve risk adjustment of cancer surgical outcomes | Dobbins, TA; Creighton, N; Currow, DC; Young, JM |
| 2019-12-01 | Low agreement between mMRC rated by patients and clinicians: Implications for practice | Ekström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC |
| 2021-01-01 | Lung, breast, and bowel cancer treatment for Aboriginal people in New South Wales: a population-based cohort study. | Fitzadam, S; Lin, E; Creighton, N; Currow, DC |
| 2015-01-01 | Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: A feasibility pilot | Johnson, MJ; Simpson, MIG; Currow, DC; Millman, RE; Hart, SP; Green, G |
| 2015-01-02 | The management of chronic breathlessness in patients with advanced and terminal illness | Ekström, MP; Abernethy, AP; Currow, DC |
| 2021-04 | Management of Dyspnea in Advanced Cancer: ASCO Guideline. | Hui, D; Bohlke, K; Bao, T; Campbell, TC; Coyne, PJ; Currow, DC; Gupta, A; Leiser, AL; Mori, M; Nava, S; Reinke, LF; Roeland, EJ; Seigel, C; Walsh, D; Campbell, ML |
| 2012-07-24 | Management of polypharmacy: Can we safely discontinue medications? | Currow, DC; Kutner, JS; Abernethy, AP |
| 2010-07-01 | Management of refractory dyspnoea: Evidence-based interventions | Davidson, PM; Currow, DC |
| 2020-04-08 | Managing the supportive care needs of those affected by COVID-19. | Bajwah, S; Wilcock, A; Towers, R; Costantini, M; Bausewein, C; Simon, ST; Bendstrup, E; Prentice, W; Johnson, MJ; Currow, DC; Kreuter, M; Wells, AU; Birring, SS; Edmonds, P; Higginson, IJ |
| 2011-03-01 | Measuring the net benefits of hospice and palliative care: A composite measure for multiple audiences-palliative net benefit | Currow, DC; Abernethy, AP; Bausewein, C; Johnson, M; Harding, R; Higginson, I |
| 2020-10-21 | Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial. | Lawlor, PG; McNamara-Kilian, MT; MacDonald, AR; Momoli, F; Tierney, S; Lacaze-Masmonteil, N; Dasgupta, M; Agar, M; Pereira, JL; Currow, DC; Bush, SH |
| 2021-01-01 | Mental wellbeing in bereaved carers: A Health Survey for England population study. | Hodiamont, F; Allgar, V; Currow, DC; Johnson, MJ |
| 2019-09-12 | Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. | Hardy, JR; Skerman, H; Philip, J; Good, P; Currow, DC; Mitchell, G; Yates, P |
| 2020-08 | Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer: A Prospective Longitudinal Multinational Study (EPCCS). | Ekström, MP; Palmqvist, S; Currow, DC; Sjøgren, P; Kurita, GP; Jakobsen, G; Kaasa, S; Hjermstad, M |
| 2016-01-01 | Minimal clinically important difference and Edmonton Symptom Assessment Scale | Johnson, MJ; Currow, DC |
| 2021-03-25 | Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study. | Ekström, M; Bornefalk, H; Sköld, CM; Janson, C; Blomberg, A; Sandberg, J; Bornefalk-Hermansson, A; Currow, DC; Johnson, MJ; Sundh, J |
